Cardiovascular Innovations and Applications

Cardiovascular Innovations and Applications A platinum open access & the official journal of the Great Wall International Congress of Cardiology

Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicabili

ty in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. CVIA also welcomes commentaries, case studies and reports, letters to the editor, methodology papers related to clinical trials, education and training articles, techniques and videos. CVIA was founded on the occasion of the 25th anniversary of the GW-ICC in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, and C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology. The GW-ICC is one of the largest congresses in the Asian-Pacific region and is the most comprehensive and influential academic conference on cardiology. Held as a regular annual conference since 1990, GW-ICC has provided a platform for continuing education in cardiovascular disease diagnosis, treatment, and technology training, through events that leverage the expertise of internationally renowned cardiologists and scholars from the United States, Europe and Asia. The journal is published by Compuscript on behalf of the World Journals (Beijing) Medical Technology Co., Ltd. Compuscript is an international company based in Shannon, Ireland.

This research letter identifies elevated   as an independent predictor of reduced   emptying velocity in  , with a nomog...
26/12/2025

This research letter identifies elevated as an independent predictor of reduced emptying velocity in , with a nomogram integrating FGF‑23, AF chronicity, and CHF outperforming CHA2DS2‑VA, offering a tool for risk stratification.

:

Fibroblast growth factor-23 (FGF-23) emerges as a critical predictor of reduced left atrial appendage emptying velocity in AF patients, linking elevated levels to stroke risk via atrial fibrosis.

This  review summarizes  -based, imaging-guided, and   approaches for predicting and localizing idiopathic ventricular a...
18/12/2025

This review summarizes -based, imaging-guided, and approaches for predicting and localizing idiopathic ventricular arrhythmias, compares their strengths and limitations, and highlights future directions to improve guidance for .

:

Reviewing ECG, imaging, & AI for premature ventricular contractions (PVCs) localization in outflow tracts. Covers clinical challenges, trends, & IVA innovations.

This mini review in Cardiovascular Innovations and Applications - CVIA Journal highlights how   is advancing   diagnosis...
12/12/2025

This mini review in Cardiovascular Innovations and Applications - CVIA Journal highlights how is advancing diagnosis by improving early detection and prognostic accuracy, while emphasizing risks from data limitations, the promise of , and key ethical and technical challenges ahead.

:

This mini review explores AI's role in Coronary heart disease diagnosis, enhancing accuracy and personalization while addressing challenges in data reliability, ethics, and regulation.

This   study uses brain MRI to explore the correlation between   and brain structural changes and complications, and sum...
04/12/2025

This study uses brain MRI to explore the correlation between and brain structural changes and complications, and summarizes the key genes involved in the pathophysiological mechanisms underlying heart-brain diseases.

:

Advancements in Magnetic resonance imaging reveal heart disease impacts brain structure. Exploring heart-brain links aids in screening, prevention, and intervention of related disorders.

This   study evaluating whether   might be associated with under-utilization of   at discharge among hospitalized patien...
28/11/2025

This study evaluating whether might be associated with under-utilization of at discharge among hospitalized patients with and LVEF

Malnutrition in heart failure patients is linked to lower prescription rates of guideline-directed medical therapy, highlighting crucial gaps in treatment adherence

Using two-step   and   analyses, this   study identifies immune cell types that promote or protect against   (AD) and hi...
20/11/2025

Using two-step and analyses, this study identifies immune cell types that promote or protect against (AD) and highlights as a key mediator linking immune cell activity to AD risk.

:

Study uncovers immune cell and inflammatory protein links to aortic dissection, revealing potential therapeutic targets for better prevention and treatment.

This review in Cardiovascular Innovations and Applications - CVIA Journal discusses  -related cognitive impairment, high...
13/11/2025

This review in Cardiovascular Innovations and Applications - CVIA Journal discusses -related cognitive impairment, highlighting compromised kidney function, perioperative mechanisms in , and the importance of early intervention to prevent postoperative .

:

Chronic Kidney Disease patients face higher risks of cognitive decline after heart surgery. Exploring mechanisms behind this can improve outcomes and reduce complications.

This editorial highlights emerging insights into immune and   mechanisms driving   (AD), identifying key immune cell sub...
13/11/2025

This editorial highlights emerging insights into immune and mechanisms driving (AD), identifying key immune cell subsets and inflammatory proteins with causal roles in AD pathogenesis and therapeutic potential for precision . Fudan University

:

This editorial uncovers immune and inflammatory pathways driving aortic dissection, highlighting key cell subsets and proteins as potential therapeutic targets.

This editorial highlights the emerging role of immune regulation in  , emphasizing key genes   and   as novel diagnostic...
13/11/2025

This editorial highlights the emerging role of immune regulation in , emphasizing key genes and as novel diagnostic and therapeutic targets, and showcasing innovative , and cell-based strategies advancing . Zhengzhou University Boston University Chobanian & Avedisian School of Medicine

:

This editorial explores immune mechanisms in myocardial infarction, spotlighting S100A12 and BCL6 as key biomarkers driving next-gen precision cardiology.

This editorial highlights the emerging role of extracellular vesicle–derived   as ultra‑early   and therapeutic targets ...
11/11/2025

This editorial highlights the emerging role of extracellular vesicle–derived as ultra‑early and therapeutic targets in , marking a paradigm shift toward and personalized intervention in . .li.73 Harvard Medical School

:

This editorial discusses extracellular vesicle‑miRNAs as early biomarkers and therapeutic targets, redefining precision care in acute myocardial infarction.

This research letter integrates   and   analyses to identify   genes   and UBC as key regulators of   (MI) via  , reveal...
06/11/2025

This research letter integrates and analyses to identify genes and UBC as key regulators of (MI) via , revealing BCL2L1 as a promising therapeutic target for MI intervention.

:

This study explores PANoptosis as a therapeutic target for myocardial infarction using Mendelian randomization and multi-omics data analysis.

Address

Bay K, Shannon Industrial Estate
Shannon
V14WK53

Alerts

Be the first to know and let us send you an email when Cardiovascular Innovations and Applications posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cardiovascular Innovations and Applications:

Share

Category

Our Story

Cardiovascular Innovations and Applications (CVIA) was founded on the occasion of the 25th anniversary of the GW-ICC in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, who will serve as Founding Editor. C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology, has recently been appointed Editor-in-Chief of the new journal, which will publish its first issue to coincide with the GW-ICC meeting in October 2015 in Beijing, China.